SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001725160-23-000196
Filing Date
2023-11-06
Accepted
2023-11-06 09:06:59
Documents
72
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q zntl-20230930.htm   iXBRL 10-Q 1558298
2 EX-31.1 zentalis10-qq32023ex311.htm EX-31.1 10887
3 EX-31.2 zentalis10-qq32023ex312.htm EX-31.2 11131
4 EX-32.1 zentalis10-qq32023ex321.htm EX-32.1 5594
5 EX-32.2 zentalis10-qq32023ex322.htm EX-32.2 5175
11 zntl-20230930_g1.jpg GRAPHIC 169586
  Complete submission text file 0001725160-23-000196.txt   7122232

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zntl-20230930.xsd EX-101.SCH 38910
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zntl-20230930_cal.xml EX-101.CAL 75013
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zntl-20230930_def.xml EX-101.DEF 192990
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zntl-20230930_lab.xml EX-101.LAB 590067
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zntl-20230930_pre.xml EX-101.PRE 389413
66 EXTRACTED XBRL INSTANCE DOCUMENT zntl-20230930_htm.xml XML 827673
Mailing Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018
Business Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Filer) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39263 | Film No.: 231378608
SIC: 2834 Pharmaceutical Preparations